AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Rohan Singh, Hamid Ebrahimi Orimi, Praveen Kumar Raju Pedabaliyarasimhuni, Corinne A. Hoesli, Moncef Chioua
Natura: Artículo Open Access
Pubblicazione: Wiley 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867017935454732288
author Rohan Singh
Hamid Ebrahimi Orimi
Praveen Kumar Raju Pedabaliyarasimhuni
Corinne A. Hoesli
Moncef Chioua
author_facet Rohan Singh
Hamid Ebrahimi Orimi
Praveen Kumar Raju Pedabaliyarasimhuni
Corinne A. Hoesli
Moncef Chioua
Rohan Singh
Hamid Ebrahimi Orimi
Praveen Kumar Raju Pedabaliyarasimhuni
Corinne A. Hoesli
Moncef Chioua
collection Wiley Open Access
contents AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review Rohan Singh Hamid Ebrahimi Orimi Praveen Kumar Raju Pedabaliyarasimhuni Corinne A. Hoesli Moncef Chioua Biotechnology Journal ABSTRACTRecent advancements in stem cell research forge them into one of the most promising sources for cell therapy applications. Quality monitoring in stem cell culture is essential for ensuring consistency, viability, and therapeutic efficacy. Traditional methods involve periodic sampling for conducting endpoint assays such as cell viability, proliferation, and differentiation using microscopy and flow cytometry, which are labor‐intensive and often lack the real‐time monitoring of the processes for scale‐up applications. This paper explores artificial intelligence (AI)‐driven approaches for real‐time quality control, integrating machine vision, predictive modeling, and sensor‐based monitoring. AI models analyze high‐resolution imaging and multi‐sensor data to dynamically track critical quality attributes (CQAs), including cell morphology, proliferation rate, differentiation potential, environmental stability (pH, oxygen, and nutrient levels), genetic integrity, and contamination risks. These models enable automated anomaly detection, differentiation tracking, and adaptive culture optimization. By leveraging real‐time feedback systems and multi‐omics integration, AI‐driven techniques enhance scalability, reproducibility, and process automation in stem cell biomanufacturing. This review outlines current advancements, challenges, and future directions in AI‐assisted quality monitoring and highlights its potential to improve fully automated, scalable production of stem cell lines for clinical translation and regulatory compliance in regenerative medicine. 10.1002/biot.70100 http://creativecommons.org/licenses/by-nc/4.0/
doi_str_mv 10.1002/biot.70100
format Artículo Open Access
id wiley_oa_10_1002_biot_70100
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review
Rohan Singh
Hamid Ebrahimi Orimi
Praveen Kumar Raju Pedabaliyarasimhuni
Corinne A. Hoesli
Moncef Chioua
Biotechnology Journal
AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review Rohan Singh Hamid Ebrahimi Orimi Praveen Kumar Raju Pedabaliyarasimhuni Corinne A. Hoesli Moncef Chioua Biotechnology Journal ABSTRACTRecent advancements in stem cell research forge them into one of the most promising sources for cell therapy applications. Quality monitoring in stem cell culture is essential for ensuring consistency, viability, and therapeutic efficacy. Traditional methods involve periodic sampling for conducting endpoint assays such as cell viability, proliferation, and differentiation using microscopy and flow cytometry, which are labor‐intensive and often lack the real‐time monitoring of the processes for scale‐up applications. This paper explores artificial intelligence (AI)‐driven approaches for real‐time quality control, integrating machine vision, predictive modeling, and sensor‐based monitoring. AI models analyze high‐resolution imaging and multi‐sensor data to dynamically track critical quality attributes (CQAs), including cell morphology, proliferation rate, differentiation potential, environmental stability (pH, oxygen, and nutrient levels), genetic integrity, and contamination risks. These models enable automated anomaly detection, differentiation tracking, and adaptive culture optimization. By leveraging real‐time feedback systems and multi‐omics integration, AI‐driven techniques enhance scalability, reproducibility, and process automation in stem cell biomanufacturing. This review outlines current advancements, challenges, and future directions in AI‐assisted quality monitoring and highlights its potential to improve fully automated, scalable production of stem cell lines for clinical translation and regulatory compliance in regenerative medicine. 10.1002/biot.70100 http://creativecommons.org/licenses/by-nc/4.0/
title AI‐Driven Quality Monitoring and Control in Stem Cell Cultures: A Comprehensive Review
topic Biotechnology Journal
url https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70100